| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $333.4M | — | +46.1% |
| Cost of Revenue | $68.7M | — | +253.0% |
| Gross Profit | $264.8M | — | +26.8% |
| R&D Expense | $173.0M | — | +147.4% |
| SG&A Expense | $103.6M | — | +242.8% |
| Operating Income | -$137.4M | — | -445.7% |
| Pre-tax Income | -$141.7M | — | -401.4% |
| Income Tax | $678K | — | -68.3% |
| Net Income | -$142.4M | — | -417.3% |
| EPS (Basic) | -$0.27 | — | -775.0% |
| EPS (Diluted) | -$0.27 | — | -775.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $405.7M | +0.5% | -34.4% |
| Short-term Investments | $1.23B | -1.6% | — |
| Accounts Receivable | $188.4M | -24.0% | — |
| Current Assets | $1.94B | -3.4% | — |
| Total Assets | $2.29B | -2.4% | — |
| Current Liabilities | $774.5M | -0.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $97.3M | — | +0.1% |
| Capital Expenditures | $7.8M | — | +793.8% |
| Investing Cash Flow | -$7.4M | — | -118.1% |
| Financing Cash Flow | -$87.5M | — | — |
| Free Cash Flow | $89.5M | — | -7.1% |
| — |
| Total Liabilities | $833.8M | -0.4% | — |
| Stockholders' Equity | $1.46B | -3.6% | +6.3% |